(Q45863576)

17 December 2017

title

Gene therapy: Targeting β-thalassaemia (English)

1 reference

17 December 2017

0 references

Derek A Persons

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

17 December 2017

published in

Nature

1 reference

17 December 2017

volume

467

1 reference

17 December 2017

issue

7313

1 reference

17 December 2017

page(s)

277-278

1 reference

17 December 2017

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

cites work

1 reference

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

21 January 2018

1 reference

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

21 January 2018

1 reference

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

Roles of HMGA proteins in cancer

21 January 2018

1 reference

Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

21 January 2018

1 reference

Prospects for Human Gene Therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20844523

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/467277A

1 reference

17 December 2017

Dimensions Publication ID

1026372260

0 references

1 reference

17 December 2017